SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-031673
Filing Date
2023-04-21
Accepted
2023-04-21 16:01:13
Documents
3
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea177082-def14a_jasper.htm DEF 14A 574897
2 GRAPHIC image_001.jpg GRAPHIC 213362
3 GRAPHIC image_002.jpg GRAPHIC 207116
  Complete submission text file 0001213900-23-031673.txt   1155337
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39138 | Film No.: 23836259
SIC: 2836 Biological Products, (No Diagnostic Substances)